SNCA and depressive symptom measurement: It favors the concept of pathological process beginning in the peripheral nervous system with further centripetal spreading of alpha-synuclein in a subgroup of PD patients and hence the associated neurodegeneration causing a significantly higher autonomic dysfunction, higher depression burden as well as hallucinations through dysregulation of dopaminergic and noradrenergic system in the brainstem.